Lv2
200 积分 2024-10-30 加入
Toll-like receptor 7 and interferon-α synergy establishes a positive feedback loop to potentiate antiviral immunity in chronic hepatitis B
8天前
已完结
P124 A patient record embedded electronic form and registry to facilitate individual and population based care for patients with chronic liver disease
2个月前
已关闭
Novel HBV Biomarkers-Guided NAs Withdrawal Strategy Promotes HBsAg Clearance in Asian CHB Patients: A Randomized Controlled Trial
6个月前
已完结
Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?
6个月前
已完结
Discovery of a first-in-class orally available HBV cccDNA inhibitor
9个月前
已完结
Performance of the AASLD, EASL, and APASL Clinical Practice Guidelines in"grey zone"stages of Chinese patients with chronic hepatitis B
9个月前
已完结
Mitochondrial HIGD1A inhibits hepatitis B virus transcription and replication through the cellular PNKD-NF-κB-NR2F1 nexus
9个月前
已完结
Functional Comparison of Interferon‐α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon‐α and Interferon‐γ Signaling
9个月前
已完结
Toll‐like receptor 7 agonist, GS‐986, is an immune‐stimulant inducing follicular helper T cells and expanding HBs antigen‐specific B cells in vitro
1年前
已完结
Exploration of 1-(indolin-1-yl)-2-(thiazol-2-yl)ethan-1-one derivatives as novel anti-HBV agent with potential TLR7-agonistic effect
1年前
已完结
皖公网安备34019202002308
